 | • レポートコード：MRC2304J0013 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、223ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査資料によると、世界の酸化ストレスアッセイ市場規模は、2021年869.63百万ドルから2022年に961.62百万ドルへと拡大、その後2027年までに年平均10.75％成長して1,605.13百万ドルに達する見通しです。本書は、酸化ストレスアッセイの世界市場を対象とした調査・分析結果を整理したものであり、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品＆サービス別分析（消耗品、器具、サービス）、技術別分析（クロマトグラフィー、ELISA、フローサイトメトリー、ハイコンテントスクリーニング、ラベルフリー検出）、検査種類別分析（抗酸化能アッセイ、酵素ベースアッセイ、間接アッセイ、活性酸素種ベースアッセイ）、疾患種類別分析（癌、心血管疾患、糖尿病、呼吸器疾患）、地域別分析（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）、競争状況、企業情報などの項目を掲載しています。なお、本書には、Abcam plc、AMS Biotechnology (Europe) Ltd.、Arbor Assays、Biovision, Inc.、Callegari Srl、Cayman Chemical、Cell Biolabs, Inc.、Eagle Biosciences, Inc.、Enzo Biochem, Inc.、Genox Corporation、Hycult Biotechなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の酸化ストレスアッセイ市場規模：製品＆サービス別 - 消耗品の市場規模 - 器具の市場規模 - サービスの市場規模 ・世界の酸化ストレスアッセイ市場規模：技術別 - クロマトグラフィーの市場規模 - ELISAの市場規模 - フローサイトメトリーの市場規模 - ハイコンテントスクリーニングの市場規模 - ラベルフリー検出の市場規模 ・世界の酸化ストレスアッセイ市場規模：検査種類別 - 抗酸化能アッセイの市場規模 - 酵素ベースアッセイの市場規模 - 間接アッセイの市場規模 - 活性酸素種ベースアッセイの市場規模 ・世界の酸化ストレスアッセイ市場規模：疾患種類別 - 癌における市場規模 - 心血管疾患における市場規模 - 糖尿病における市場規模 - 呼吸器疾患における市場規模 ・世界の酸化ストレスアッセイ市場規模：地域別 - 南北アメリカの酸化ストレスアッセイ市場規模 アメリカの酸化ストレスアッセイ市場規模 カナダの酸化ストレスアッセイ市場規模 ブラジルの酸化ストレスアッセイ市場規模 ... - アジア太平洋の酸化ストレスアッセイ市場規模 日本の酸化ストレスアッセイ市場規模 中国の酸化ストレスアッセイ市場規模 インドの酸化ストレスアッセイ市場規模 韓国の酸化ストレスアッセイ市場規模 台湾の酸化ストレスアッセイ市場規模 ... - ヨーロッパ/中東/アフリカの酸化ストレスアッセイ市場規模 イギリスの酸化ストレスアッセイ市場規模 ドイツの酸化ストレスアッセイ市場規模 フランスの酸化ストレスアッセイ市場規模 ロシアの酸化ストレスアッセイ市場規模 ... - その他地域の酸化ストレスアッセイ市場規模 ・競争状況 ・企業情報 |
The Global Oxidative Stress Assay Market size was estimated at USD 869.63 million in 2021 and expected to reach USD 961.62 million in 2022, and is projected to grow at a CAGR 10.75% to reach USD 1,605.13 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Oxidative Stress Assay to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product & Service, the market was studied across Consumables, Instruments, and Services. The Consumables is further studied across Kits and Reagents.
Based on Technology, the market was studied across Chromatography, Elisa, Flow Cytometry, High-Content Screening, Label-Free Detection, and Microscopy.
Based on Test Type, the market was studied across Antioxidant Capacity Assays, Enzyme-Based Assays, Indirect Assays, and Reactive Oxygen Species-Based Assays.
Based on Disease Type, the market was studied across Cancer, Cardiovascular Diseases, Diabetes, and Respiratory Diseases.
Based on End-user, the market was studied across Academic Research Institutes, Clinical Laboratories, Contract Research Organizations, Cosmetic Industry, and Pharmaceutical and Biotechnology Companies.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Oxidative Stress Assay market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Oxidative Stress Assay Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Oxidative Stress Assay Market, including Abcam plc, AMS Biotechnology (Europe) Ltd., Arbor Assays, Biovision, Inc., Callegari Srl, Cayman Chemical, Cell Biolabs, Inc., Eagle Biosciences, Inc., Enzo Biochem, Inc., Genox Corporation, Hycult Biotech, Immunochemistry Technologies, LLC, Kamiya Biomedical Company, Mega Tip San.Tic.Ltd.Sti., Merck KGaA, Oxford Biomedical Research, Promega Corporation, Qiagen N.V., Thermo Fisher Scientific, Inc., and Toxys B.V..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Oxidative Stress Assay Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Oxidative Stress Assay Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Oxidative Stress Assay Market?
4. What is the competitive strategic window for opportunities in the Global Oxidative Stress Assay Market?
5. What are the technology trends and regulatory frameworks in the Global Oxidative Stress Assay Market?
6. What is the market share of the leading vendors in the Global Oxidative Stress Assay Market?
7. What modes and strategic moves are considered suitable for entering the Global Oxidative Stress Assay Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing R&D expenditure in the pharmaceutical & biopharmaceutical industries
5.1.1.2. Rising incidence of various cellular diseases
5.1.2. Restraints
5.1.2.1. High cost of instruments
5.1.2.2. Lack of awareness among the population
5.1.3. Opportunities
5.1.3.1. Increasing applications of oxidative stress measurement in the cosmetic industry
5.1.3.2. Technological advancement in high-content screening for drug discovery
5.1.4. Challenges
5.1.4.1. Lack of trained personnel for emerging technologies
5.2. Cumulative Impact of COVID-19
6. Oxidative Stress Assay Market, by Product & Service
6.1. Introduction
6.2. Consumables
6.3.1. Kits
6.3.2. Reagents
6.3. Instruments
6.4. Services
7. Oxidative Stress Assay Market, by Technology
7.1. Introduction
7.2. Chromatography
7.3. Elisa
7.4. Flow Cytometry
7.5. High-Content Screening
7.6. Label-Free Detection
7.7. Microscopy
8. Oxidative Stress Assay Market, by Test Type
8.1. Introduction
8.2. Antioxidant Capacity Assays
8.3. Enzyme-Based Assays
8.4. Indirect Assays
8.5. Reactive Oxygen Species-Based Assays
9. Oxidative Stress Assay Market, by Disease Type
9.1. Introduction
9.2. Cancer
9.3. Cardiovascular Diseases
9.4. Diabetes
9.5. Respiratory Diseases
10. Oxidative Stress Assay Market, by End-user
10.1. Introduction
10.2. Academic Research Institutes
10.3. Clinical Laboratories
10.4. Contract Research Organizations
10.5. Cosmetic Industry
10.6. Pharmaceutical and Biotechnology Companies
11. Americas Oxidative Stress Assay Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Oxidative Stress Assay Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Oxidative Stress Assay Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis, By Key Player
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. Abcam plc
15.1.1. Business Overview
15.1.2. Key Executives
15.1.3. Product & Services
15.2. AMS Biotechnology (Europe) Ltd.
15.2.1. Business Overview
15.2.2. Key Executives
15.2.3. Product & Services
15.3. Arbor Assays
15.3.1. Business Overview
15.3.2. Key Executives
15.3.3. Product & Services
15.4. Biovision, Inc.
15.4.1. Business Overview
15.4.2. Key Executives
15.4.3. Product & Services
15.5. Callegari Srl
15.5.1. Business Overview
15.5.2. Key Executives
15.5.3. Product & Services
15.6. Cayman Chemical
15.6.1. Business Overview
15.6.2. Key Executives
15.6.3. Product & Services
15.7. Cell Biolabs, Inc.
15.7.1. Business Overview
15.7.2. Key Executives
15.7.3. Product & Services
15.8. Eagle Biosciences, Inc.
15.8.1. Business Overview
15.8.2. Key Executives
15.8.3. Product & Services
15.9. Enzo Biochem, Inc.
15.9.1. Business Overview
15.9.2. Key Executives
15.9.3. Product & Services
15.10. Genox Corporation
15.10.1. Business Overview
15.10.2. Key Executives
15.10.3. Product & Services
15.11. Hycult Biotech
15.11.1. Business Overview
15.11.2. Key Executives
15.11.3. Product & Services
15.12. Immunochemistry Technologies, LLC
15.12.1. Business Overview
15.12.2. Key Executives
15.12.3. Product & Services
15.13. Kamiya Biomedical Company
15.13.1. Business Overview
15.13.2. Key Executives
15.13.3. Product & Services
15.14. Mega Tip San.Tic.Ltd.Sti.
15.14.1. Business Overview
15.14.2. Key Executives
15.14.3. Product & Services
15.15. Merck KGaA
15.15.1. Business Overview
15.15.2. Key Executives
15.15.3. Product & Services
15.16. Oxford Biomedical Research
15.16.1. Business Overview
15.16.2. Key Executives
15.16.3. Product & Services
15.17. Promega Corporation
15.17.1. Business Overview
15.17.2. Key Executives
15.17.3. Product & Services
15.18. Qiagen N.V.
15.18.1. Business Overview
15.18.2. Key Executives
15.18.3. Product & Services
15.19. Thermo Fisher Scientific, Inc.
15.19.1. Business Overview
15.19.2. Key Executives
15.19.3. Product & Services
15.20. Toxys B.V.
15.20.1. Business Overview
15.20.2. Key Executives
15.20.3. Product & Services
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing